DVLP Studio + DVLP Agency
Intelligent drug
development.
One place to develop a drug asset from molecule to commercialization, built on a governed AI layer that earns trust one verified action at a time.
10–15 years
Time to develop a drug
DiMasi et al., Tufts CSDD
$2.6B
Average cost per approved drug
DiMasi et al., Tufts CSDD
~90%
Of clinical-stage assets never reach approval
BIO / Informa
Most of that spend is committed before the data that would have stopped it arrives. DVLP shortens the loop between evidence and decision.
See how →Develop with us.
Bring one of your programs. We'll show you the Studio working on it — the Canon, the governed agents, and a real deliverable in minutes.
Contact us